background preloader

Secteur médical en Europe

Facebook Twitter

FRONTIERS IN MICROBIOOGY 22/08/16 MRSA Prevalence and Associated Risk Factors among Health-Care Workers in Non-outbreak Situations in the Dutch-German EUREGIO. Introduction Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most important hospital-associated (HA) pathogens (Voss and Doebbeling, 1995).

FRONTIERS IN MICROBIOOGY 22/08/16 MRSA Prevalence and Associated Risk Factors among Health-Care Workers in Non-outbreak Situations in the Dutch-German EUREGIO

Although its prevalence among patients decreased in several European countries (e.g., UK, France, and Germany) during the last years, the MRSA prevalence increased in other countries (e.g., Norway and Poland; In healthcare institutions, MRSA can be transmitted between patients, or through the hands, clothes, or equipment of healthcare workers (HCWs), and the environment (Haley et al., 1982; Hardy et al., 2006; Henderson, 2006). Furthermore, it has been reported that HCWs have been the source of MRSA outbreaks in several cases (Vonberg et al., 2006). In a systematic review of Albricht et al., in which 127 studies and outbreak reports published between January 1980 and March 2006 were reviewed, transmission of MRSA from HCWs to patients was likely in 63 of 68 (93%) studies as shown by genotyping (Albrich and Harbarth, 2008).

Ethics. EUROSURVEILLANCE 18/08/16 The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohor. AJ Stewardson 1 2 , A Allignol 3 4 , J Beyersmann 3 , N Graves 5 , M Schumacher 4 , R Meyer 6 , E Tacconelli 7 8 , G De Angelis 7 , C Farina 9 , F Pezzoli 9 , X Bertrand 10 , H Gbaguidi-Haore 10 , J Edgeworth 11 , O Tosas 11 , JA Martinez 12 , MP Ayala-Blanco 12 , A Pan 13 , A Zoncada 13 , CA Marwick 14 , D Nathwani 14 , H Seifert 15 16 , N Hos 15 , S Hagel 17 , M Pletz 17 , S Harbarth 1 , the TIMBER Study Group 18 + Author affiliations.

EUROSURVEILLANCE 18/08/16 The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohor

EUROSURVEILLANCE 19/11/15 Incidence of invasive meticillin-resistant Staphylococcus aureus infections in Germany, 2010 to 2014. J Walter 1 , S Haller 1 , H Blank 1 , T Eckmanns 1 , M Abu Sin 1 , J Hermes 1 + Author affiliations.

EUROSURVEILLANCE 19/11/15 Incidence of invasive meticillin-resistant Staphylococcus aureus infections in Germany, 2010 to 2014.

EUROSURVEILLANCE 05/09/13 Au sommaire:Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density b. Meticillin-resistant Staphylococcus aureus (MRSA) disseminates between hospitals serving one patient catchment area.

EUROSURVEILLANCE 05/09/13 Au sommaire: Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density by a region-wide search and follow-strategy in forty German hospitals of the EUREGIO, 2009 to 2011  – guatemalt

Successful prevention and control requires concerted efforts and regional surveillance.

EUROSURVEILLANCE 05/09/13 Au sommaire:Reduction of the nosocomial meticillin-resistant Staphylococcus aureus incidence density b

Forty hospitals located in the German EUREGIO have established a network for combating MRSA. In 2007 they agreed upon a synchronised strategy for screening of risk patients and a standard for transmission-based precautions (search and follow). The same year, the hospitals started synchronised MRSA prevention and annually reporting MRSA-data to the public health authorities. The median rate of screening cultures per 100 patients admitted increased from 4.38 in 2007 to 34.4 in 2011 (p<0.0001). Introduction Meticillin-resistant Staphylococcus aureus (MRSA) globally belongs to the most frequent causes of healthcare-associated infections [1].

In consequence, the referral of patients between regional hospitals might contribute to MRSA spread. Methods Results Table 1. Figure1. Table 2. Eurosurveillance, Volume 16, Issue 35, 01 September 2011Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia in Tampere. EUROPE 04/02/10 Scientists tackle and trace infection prevention and control.

An international team of scientists has developed an innovative way to track the transmission of methicillin-resistant Staphylococcus aureus (MRSA) in a single hospital setting.

EUROPE 04/02/10 Scientists tackle and trace infection prevention and control

Presented in the journal Science, the findings demonstrate how this unique method can 'zoom' from large-scale inter-continental transmission events to the much finer detail of person-to-person infection of MRSA in just one hospital. The findings of this study will benefit researchers who are investigating how strains have the ability to spread quickly. They can also potentially fuel the creation and implementation of new infection control strategies — both for MRSA and other superbugs that are making their presence known.

By using new very high-throughput DNA (deoxyribonucleic acid) sequencing technologies, the researchers were able to compare individual MRSA isolates from patients to accurately show their genetic relatedness. Comparison of whole genomes is what makes the new method successful, they said. EUROSURVEILLANCE 14/10/10 Au sommaire: Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challen. Weekly and monthly releases: Eurosurveillance releases: Eurosurveillance, Volume 15, Issue 41, 14 October 2010 Table of Contents Rapid communications.

EUROSURVEILLANCE 14/10/10 Au sommaire: Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challen

EFSA 16/06/09 Les agences européennes de santé publique évaluent la résistance aux antibiotiques de Staphylococcus aureus. Communiqué de presse 16 juin 2009 L’Autorité européenne de sécurité des aliments (EFSA), le Centre européen de prévention et de contrôle des maladies (ECDC) et l’Agence européenne des médicaments (EMEA) ont publié aujourd’hui un rapport scientifique commun sur le Staphylococcus aureus résistant à la méthicilline (SARM) dans les élevages, chez les animaux de compagnie et dans les aliments.

EFSA 16/06/09 Les agences européennes de santé publique évaluent la résistance aux antibiotiques de Staphylococcus aureus

Suite à une demande de la Commission européenne, le groupe scientifique de l’EFSA sur les dangers biologiques et l’ECDC ont conclu que les animaux producteurs de denrées, tels que les porcs, les veaux et les poulets de chair, sont souvent porteurs d’une souche spécifique de SARM appelée CC398, même s’ils n’en présentent aucun symptôme. Cependant, même si des aliments peuvent être contaminés par SARM, rien n’indique actuellement que l’ingestion ou la manipulation d’aliments contaminés puisse augmenter le risque pour la santé de l’homme.